Outset Medical (OM) Stock Analysis

What Outset Medical does

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

Key metrics

ETFs linked to OM

Broad-market and Healthcare sector ETFs an investor holding Outset Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Outset Medical?

Outset Medical trades under the ticker OM on NASDAQ.

Which exchange is OM listed on?

OM is listed on NASDAQ.

What sector does Outset Medical operate in?

Outset Medical is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze OM in a portfolio?

PortView shows OM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.